CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-10 | Ho Carole Chief Medical Officer | Sale | −2,857 | $24.15 | $69K | 185,577 |
| 2023-08-10 | Schuth Alexander O. COFO and Secretary | Sale | −2,853 | $24.18 | $69K | 521,761 |
| 2023-07-18 | Schuth Alexander O. COFO and Secretary | Sale | −9,702 | $30.01 | $291K | 518,989 |
| 2023-07-17 | Schuth Alexander O. COFO and Secretary | Option exercise | +10,000 | $5.28 | $53K | 538,691 |
| 2023-07-17 | Schuth Alexander O. COFO and Secretary | Sale | −10,000 | $29.60 | $296K | 528,691 |
| 2023-07-17 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −10,000 | 68,937 | ||
| 2023-07-17 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $29.60 | $49K | 133,037 |
| 2023-06-28 | SATO VICKI L Director | Sale 10b5-1 | −552 | $29.55 | $16K | 135,817 |
| 2023-06-28 | SATO VICKI L Director | Sale 10b5-1 | −1,114 | $29.98 | $33K | 134,703 |
| 2023-06-16 | Watts Ryan J. President and CEO | Option exercise | +50,000 | $0.68 | $34K | 2,289,913 |
| 2023-06-16 | Watts Ryan J. President and CEO | Sale | −50,000 | $31.40 | $1.6M | 2,239,913 |
| 2023-06-16 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) | −50,000 | 1,120,617 | ||
| 2023-06-01 | Thornberry Nancy Director | Grant or award | +4,216 | 12,713 | ||
| 2023-06-01 | Thornberry Nancy Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | Krognes Steve E. Director | Grant or award | +4,216 | 147,218 | ||
| 2023-06-01 | Krognes Steve E. Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | Tessier-Lavigne Marc Director | Grant or award | +4,216 | 1,874,572 | ||
| 2023-06-01 | Tessier-Lavigne Marc Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-06-01 | Klein Peter S Director | Grant or award | +4,216 | 15,529 | ||
| 2023-06-01 | Klein Peter S Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 |
Page 10 of 53 · 1,043 trades